Related references
Note: Only part of the references are listed.alpha-Adrenoceptor stimulation attenuates melanoma grow in mice
Sonia Maccari et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Melanoma Targeted Therapies beyond BRAF-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches
Karam Khaddour et al.
CANCERS (2021)
Vasopressin receptor 2 mutations in the nephrogenic syndrome of inappropriate antidiuresis show different mechanisms of constitutive activation for G protein coupled receptors
Vanessa Vezzi et al.
Scientific Reports (2020)
β3-Adrenoceptor as a potential immuno-suppressor agent in melanoma
Maura Calvani et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
BRL37344 stimulates GLUT4 translocation and glucose uptake in skeletal muscle via β2-adrenoceptors without causing classical receptor desensitization
Saori Mukaida et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2019)
cAMP Signaling Compartmentation: Adenylyl Cyclases as Anchors of Dynamic Signaling Complexes
Timothy B. Johnstone et al.
MOLECULAR PHARMACOLOGY (2018)
Propranolol for Off-label Treatment of Patients With Melanoma Results From a Cohort Study
Vincenzo De Giorgi et al.
JAMA ONCOLOGY (2018)
Biphasic effects of propranolol on tumour growth in B16F10 melanoma-bearing mice
Sonia Maccari et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
β-Adrenergic Signaling in Mice Housed at Standard Temperatures Suppresses an Effector Phenotype in CD8+ T Cells and Undermines Checkpoint Inhibitor Therapy
Mark J. Bucsek et al.
CANCER RESEARCH (2017)
Inhibition of Human Melanoma Growth by a Non-Cardioselective β-Blocker
Ludovic J. Wrobel et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Role of host β1-and β2-adrenergic receptors in a murine model of B16 melanoma: functional involvement of β3-adrenergic receptors
Federica Sereni et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2015)
Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression
Maura Calvani et al.
ONCOTARGET (2015)
β3-adrenergic receptor activity modulates melanoma cell proliferation and survival through nitric oxide signaling
Massimo Dal Monte et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization
Massimo Dal Monte et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines
Silvia Moretti et al.
LABORATORY INVESTIGATION (2013)
Role of endothelial nitric oxide synthase (eNOS) in chronic stress-promoted tumour growth
Antonio Barbieri et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
The selectivity of β-adrenoceptor agonists at human β1-, β2- and β3-adrenoceptors
Jillian G. Baker
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Improving Survival Rates in Two Models of Spontaneous Postoperative Metastasis in Mice by Combined Administration of a β-Adrenergic Antagonist and a Cyclooxygenase-2 Inhibitor
Ariella Glasner et al.
JOURNAL OF IMMUNOLOGY (2010)
Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases
George S. Baillie
FEBS JOURNAL (2009)
Comparative pharmacology of human β-adrenergic receptor subtypes -: characterization of stably transfected receptors in CHO cells
C Hoffmann et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Simultaneous α2B- and β2-adrenoceptor activation sensitizes the α2B-adrenoceptor for agonist-induced down-regulation
AN Desai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Desensitization of α2A-adrenoceptor signalling by modest levels of adrenaline is facilitated by β2-adrenoceptor-dependent GRK3 up-regulation
T Bawa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Psychosocial stress augments tumor development through β-adrenergic activation in mice
H Hasegawa et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2002)
Share Paper
